Loading...
Nonglycemic effects of dipeptidyl peptidase-4 inhibitors
The review considers the major nonglycemic effects of dipeptidyl peptidase-4 inhibitors commonly used in diabetological practice, by using as an example sitagliptin, the first and most investigated representative of this class.
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Russo |
| Udgivet: |
"Consilium Medicum" Publishing house
2013-01-01
|
| Serier: | Терапевтический архив |
| Fag: | |
| Online adgang: | https://ter-arkhiv.ru/0040-3660/article/view/31226 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|